UBS analyst Jon Windham upgrades First Solar (NASDAQ:FSLR) from Neutral to Buy and raises the price target from $140 to $250.
Inotiv Expands Protein/Peptide Bioanalytical Capabilities With This Deal
Contract research organization Inotiv Inc (NASDAQ:NOTV) acquired Nashville, Tennessee-based Protypia Inc for $11 million. Inotiv specializes in nonclinical and analytical drug discovery,…